Literature DB >> 12798139

To create the correct microenvironment: three-dimensional heterotypic collagen assays for human breast epithelial morphogenesis and neoplasia.

Thorarinn Gudjonsson1, Lone Rønnov-Jessen, René Villadsen, Mina J Bissell, Ole William Petersen.   

Abstract

The normal human breast comprises an inner layer of luminal epithelial cells and an outer layer of myoepithelial cells separated from the connective tissue stroma by an intact basement membrane. In breast cancer, tumor cells are in direct contact with the surrounding highly activated collagenous stroma, with little or no discernible myoepithelial fence from the original double-layered structure. To understand the evolution of these two scenarios, we took advantage of a three-dimensional hydrated collagen gel approach. The contribution of myoepithelial cells to normal morphogenesis was studied by ablation and rescue experiments, and genes regulated on tumor cell-fibroblast interaction were identified in a tumor environment assay. In normal breast morphogenesis, the ability to correctly polarize sialomucin to the luminal membrane of emerging acini was used as a criterion for apical polarity and functional differentiation. In the assay of breast neoplasia, the consequence of reciprocal tumor cell-fibroblast interaction was addressed morphologically as well as by a differential display approach. Normal breast epithelial cells were purified immunomagnetically and an established cell line, MCF-7, was used as a surrogate tumor cell. With regard to the importance of myoepithelial cells in normal breast epithelial morphogenesis, the collagen gel assay elucidated the following subtleties: In contrast to culturing in basement membrane gels, luminal epithelial cells when cultured alone made structures that were all inversely polarized. This aberrant polarity could be rescued by co-culture with myoepithelial cells. The molecular activity of myoepithelial cells responsible for correct morphogenesis was narrowed down to the laminin-1 component of the basement membrane. As for the consequence of interaction of tumor cells with connective tissue fibroblasts, the assay allowed us to identify a hitherto undescribed gene referred to as EPSTI1. The relevance of the assay-based identification of regulated genes was confirmed in a series of breast carcinomas in which EPSTI1 was highly upregulated compared with normal breast. Few if any of these observations would have been possible on two-dimensional tissue culture plastic.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798139      PMCID: PMC2933212          DOI: 10.1016/s1046-2023(03)00031-8

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  72 in total

1.  Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas.

Authors:  K Malzahn; M Mitze; M Thoenes; R Moll
Journal:  Virchows Arch       Date:  1998-08       Impact factor: 4.064

2.  Laminin fragment E4 inhibition studies: basement membrane assembly and embryonic lung epithelial cell polarization requires laminin polymerization.

Authors:  L Schuger; P Yurchenco; N K Relan; Y Yang
Journal:  Int J Dev Biol       Date:  1998-03       Impact factor: 2.203

3.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

4.  Maintenance of polarity and a dual cell population in adenoid cystic carcinoma of the breast: an immunohistochemical study.

Authors:  M Kasami; S J Olson; J F Simpson; D L Page
Journal:  Histopathology       Date:  1998-03       Impact factor: 5.087

5.  Serial analysis of gene expression.

Authors:  V E Velculescu; L Zhang; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

6.  Isolation of pure populations of epithelial and myoepithelial cells from the normal human mammary gland using immunomagnetic separation with Dynabeads.

Authors:  J J Gomm; P J Browne; R C Coope; Q Y Liu; L Buluwela; R C Coombes
Journal:  Anal Biochem       Date:  1995-03-20       Impact factor: 3.365

Review 7.  Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction.

Authors:  L Rønnov-Jessen; O W Petersen; M J Bissell
Journal:  Physiol Rev       Date:  1996-01       Impact factor: 37.312

8.  Role of laminin-1 and TGF-beta 3 in acinar differentiation of a human submandibular gland cell line (HSG).

Authors:  M P Hoffman; M C Kibbey; J J Letterio; H K Kleinman
Journal:  J Cell Sci       Date:  1996-08       Impact factor: 5.285

9.  Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.

Authors:  V M Weaver; O W Petersen; F Wang; C A Larabell; P Briand; C Damsky; M J Bissell
Journal:  J Cell Biol       Date:  1997-04-07       Impact factor: 10.539

10.  Epimorphin functions as a key morphoregulator for mammary epithelial cells.

Authors:  Y Hirai; A Lochter; S Galosy; S Koshida; S Niwa; M J Bissell
Journal:  J Cell Biol       Date:  1998-01-12       Impact factor: 10.539

View more
  36 in total

Review 1.  Tissue architecture: the ultimate regulator of breast epithelial function.

Authors:  Mina J Bissell; Aylin Rizki; I Saira Mian
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

Review 2.  The normal microenvironment directs mammary gland development.

Authors:  Erin J McCave; Cheryl A P Cass; Karen J L Burg; Brian W Booth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-09-08       Impact factor: 2.673

3.  Automated local bright feature image analysis of nuclear protein distribution identifies changes in tissue phenotype.

Authors:  David W Knowles; Damir Sudar; Carol Bator-Kelly; Mina J Bissell; Sophie A Lelièvre
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-10       Impact factor: 11.205

4.  Spheroid-based drug screen: considerations and practical approach.

Authors:  Juergen Friedrich; Claudia Seidel; Reinhard Ebner; Leoni A Kunz-Schughart
Journal:  Nat Protoc       Date:  2009-02-12       Impact factor: 13.491

5.  Interconnected contribution of tissue morphogenesis and the nuclear protein NuMA to the DNA damage response.

Authors:  Pierre-Alexandre Vidi; Gurushankar Chandramouly; Matthew Gray; Lei Wang; Er Liu; Joseph J Kim; Vassilis Roukos; Mina J Bissell; Prabhas V Moghe; Sophie A Lelièvre
Journal:  J Cell Sci       Date:  2012-02-13       Impact factor: 5.285

Review 6.  Myoepithelial cells: pathology, cell separation and markers of myoepithelial differentiation.

Authors:  Catherine Clarke; Jennifer Sandle; Sunil R Lakhani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-07       Impact factor: 2.673

7.  A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds.

Authors:  Claudia Göttlich; Lena C Müller; Meik Kunz; Franziska Schmitt; Heike Walles; Thorsten Walles; Thomas Dandekar; Gudrun Dandekar; Sarah L Nietzer
Journal:  J Vis Exp       Date:  2016-04-06       Impact factor: 1.355

8.  Human breast cancer histoid: an in vitro 3-dimensional co-culture model that mimics breast cancer tissue.

Authors:  Pavinder Kaur; Brenda Ward; Baisakhi Saha; Lillian Young; Susan Groshen; Geza Techy; Yani Lu; Roscoe Atkinson; Clive R Taylor; Marylou Ingram; S Ashraf Imam
Journal:  J Histochem Cytochem       Date:  2011-10-27       Impact factor: 2.479

9.  Three-dimensional culture of human breast epithelial cells: the how and the why.

Authors:  Pierre-Alexandre Vidi; Mina J Bissell; Sophie A Lelièvre
Journal:  Methods Mol Biol       Date:  2013

10.  Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.

Authors:  Julio E Celis; José M A Moreira; Irina Gromova; Teresa Cabezón; Pavel Gromov; Tao Shen; Vera Timmermans; Fritz Rank
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.